BMRN vs VAL
As of Sep 20, 2026, Biomarin Pharmaceutical (BMRN) scores 4.9/10 and Valaris (VAL) 4.6/10 on AlphaStocks' five-model composite, so BMRN scores higher. BMRN trades 39% above its model fair value.
BMRN
BIOMARIN PHARMACEUTICAL INC
4.9
Weak
$63.94
VAL
Valaris Ltd
4.6
Weak
$83.77
BMRN vs VAL: Which is the Better Investment?
BIOMARIN PHARMACEUTICAL INC (BMRN) scores 4.9/10 while Valaris Ltd (VAL) scores 4.6/10 on AlphaStocks' composite model. BIOMARIN PHARMACEUTICAL INC has the higher composite rating of Weak. On a P/E basis, Valaris Ltd trades at 6.0x, making it the more attractively priced of the two.
This comparison is algorithmically generated and is not financial advice.
| Metric | BMRN | VAL |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 4.9/10▲ | 4.6/10 |
| Rating | Weak▲ | Weak |
| Price | $63.94 | $83.77 |
| P/E Ratio | 36.2 | 6.0▲ |
| ROE | 5.7% | 35.0%▲ |
| Market Cap | $13B | $6B |
| Fair Value | $45.94 | — |
| Dividend Yield | — | — |
| Sector Rank | #118 of 168▲ | #37 of 80 |
| Model Verdicts | ||
| Piotroski | Neutral | Strong▲ |
| Buffett | Neutral | Attractive▲ |
| Graham | Caution | Neutral▲ |
| Lynch | Neutral | Neutral |
| Greenblatt | Neutral | Attractive▲ |
Related comparisons
BMRN vs VAL: Which Stock Scores Higher?
BIOMARIN PHARMACEUTICAL INC (BMRN) is in the Health Care sector; Valaris Ltd (VAL) is in Energy. BMRN currently leads with a composite score of 4.9/10 (Weak) compared to VAL's 4.6/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer